National

Uganda to Obtain Covid-19 Vaccine from AstraZeneca

Uganda to Obtain Covid-19 Vaccine from AstraZeneca

Uganda will acquire the Covid-19 vaccine from AstraZeneca, the British-Swedish multinational pharmaceutical and biopharmaceutical company, the ministry of health has revealed.

The ministry says it applied to participate in the Global COVAX initiative for COVID -19 vaccine access and the application was approved.

“Uganda will participate in the Global COVAX initiative for COVID -19 vaccine access and has already submitted an application to this effect, which has been accepted by the Global Alliance for Vaccine Initiative (GAVI),” Dr. Diana Atwine, the ministry’s permanent secretary, said in a statement.

“Based on the evidence available and the recommendations of the Scientific Advisory Committee of the Ministry of Health, Uganda will access the vaccine from AstraZeneca.”

According to Dr. Atwine, the East African nation will also explore other traditional vaccine options such as the one from China, when they receive approval from the World Health Organization.

Once acquired, the access to the vaccine will be done in an equitable manner starting with the most vulnerable and those at more risk.

It’s important to note that on January 2, there was meeting of the National Task Force on COVID-19 chaired by President Museveni at State House, Entebbe.

“The meeting directed the Permanent Secretary, Ministry of Health to initiate preparation to ensure readiness to receive and expeditiously distribute the vaccine to the population,” reads a statement from the health ministry.

Nicholas Asingwire
Author
Nicholas Asingwire